Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Myelofibrosis Treatment Market by Type (Targeted therapy, Chemotherapy and Others), Distribution Channel (Hospital pharmacies, Retail and specialty pharmacies and Online pharmacies) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2027
... unusual type of blood cancer. The bone marrow becomes scarred, which makes it complicated to make blood cells. It belongs to a group of diseases referred as myeloproliferative disorders or myeloproliferative neoplasms. Stem cells are ... Read More
-
Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2027
... Analysis and Industry Forecast, 2027 The Natural Killer (NK) Cells Therapeutics market refers to the pharmaceutical products and therapies aimed at utilizing and enhancing the functions of natural killer cells for therapeutic purposes. Natural killer ... Read More
-
Non-Small Cell Lung Cancer Market by Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Others and Adenocarcinoma), Treatment Type (Chemotherapy, Targeted Therapy and Immunotherapy), Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy and Online Pharmacy) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027
... and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027 Non-small cell lung cancer is a form of lung cancer, where malignant tumor cells are formed in the lungs. It comprises of ... Read More
-
Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 14.7 Billion by 2028, exhibiting a growth rate (CAGR) of 21.6% during 2023-2028. Cancer is a lifestyle disease that occurs due to the abnormal growth of cells and may result in the formation ... Read More
-
Bronopol Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... US$ 1.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028. Bronopol is a colorless, water-soluble organic compound, produced by the bromination of di(hydroxymethyl)-nitromethane. It is supplied as crystals or crystalline powder, ... Read More
-
Europe Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... Breast cancer is the leading form of cancer affecting women in Europe, with approximately 400,000 new cases annually and resulting in 100,000 fatalities. This type of cancer originates from malignant tumors that develop in breast ... Read More
-
Medullary Thyroid Cancer
... in the C cells of the thyroid gland. Unlike other types of thyroid cancer that arise from follicular cells, MTC is associated with the overgrowth of these C cells and the production of elevated levels ... Read More
-
Biliary Tract Cancers (BTCs)
... various factors, including the increasing prevalence and incidence of BTCs, advancements in diagnostic technologies, evolving treatment approaches, growing awareness and screening programs, collaborative research efforts, favorable reimbursement policies, and the growing geriatric population. Despite the ... Read More
-
2023 Global Forecast for Pet Cancer Therapeutics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Chronic Myelomonocytic Leukaemia- Pipeline Insight, 2023
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Asia Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... Renub Research. Breast cancer stands as the prevailing cancer diagnosis among women and remains the primary cause of cancer-related fatalities in Asia. Breast cancer affects Asian women at an earlier age compared to their Western ... Read More
-
T cell Lymphoma -Pipeline Insight, 2023
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Global Cancer Biologics Market Size study & Forecast, by Product (Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, and Immune Checkpoint Inhibitors), by Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Others), by Distribution Channel (Hospitals, Clinics, and Others) and Regional Analysis, 2023-2030
... Leukemia, Lymphoma, Others), by Distribution Channel (Hospitals, Clinics, and Others) and Regional Analysis, 2023-2030 Global Cancer Biologics Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy ... Read More
-
Global Colorectal Cancer (CRC) Screening Market (2023 Edition): Analysis by Screening Type, End-Use, By Region, By Country: Market Insights and Forecast (2019-2029)
... Screening Market (2023 Edition)” which provides a complete analysis of the global Colorectal Cancer (CRC) Screening industry in terms of segmentation by Screening Type (Stool-based Tests, Flexible Sigmoidoscopy, Colonoscopy, CT Colonography - Virtual Colonoscopy, Other ... Read More
-
2023 Global Forecast for Peptide Cancer Vaccine Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Platinum Based Ovarian Cancer Treatment
... chemotherapy drugs that contain platinum to treat ovarian cancer. Platinum drugs, such as cisplatin and carboplatin are effective at killing cancer cells by damaging their DNA and preventing them from dividing. Carboplatin is the most ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... diagnosed prevalent cases of ES in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for ES. There are currently 11 marketed drugs for ES, the majority of which are DNA synthesis inhibitors. R&D ... Read More
-
Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, CVD, GI, OB/GYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2028
... near infrared imaging market is projected to reach USD 1.9 billion by 2028 from USD 1.0 billion in 2023, at a CAGR of 14.0% from 2023 to 2028. Factors such as the high incidence/prevalence of ... Read More
-
Global Orphan Drugs Market Size study & Forecast, by Drug Type (Biological, Non-biological) by Top Selling Drugs (Revlimid, Darzalex, Rituxan, Tafinlar, Ninlaro, Other), by Disease Type (Oncology, Hematology, Neurology, Cardiovascular, Other Disease Types) and Regional Analysis, 2023-2030
... Analysis, 2023-2030 Global Orphan Drugs Market is valued approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Orphan drugs, ... Read More
-
Global Fiducial Markers Market Size study & Forecast, by Product (Metal Based Markers, Polymer Based Markers, Other Fiducial Markers) by Modality (CT/CBCT, MRI, Radiotherapy, Ultrasound), by Cancer type (Lung Cancer, Breast Cancer, Gastric Cancer, Prostate Cancer, Other Cancers), by End User (Hospitals and Outpatient Facilities, Cancer Research Centers, Independent Radiotherapy Centers) and Regional Analysis, 2023-2030
... Cancer, Other Cancers), by End User (Hospitals and Outpatient Facilities, Cancer Research Centers, Independent Radiotherapy Centers) and Regional Analysis, 2023-2030 Global Fiducial Markers Market is valued approximately at USD XX billion in 2022 and is ... Read More
-
Global Hepatocellular Carcinoma Market - 2023-2030
... the forecast period 2023-2030. The hepatocellular carcinoma market trends show a large pipeline for hepatocellular carcinoma owing to the rising clinical trials and increasing research and development. The hepatocellular carcinoma (HCC) market of intrahepatic bile ... Read More
-
Global Prostate Cancer Market - 2023-2030
... is expected to exhibit a CAGR of 8.1% from 2023 to 2030. Prostate cancer is the second-most typical cancer arising in males, behind skin cancer. The growing prevalence of prostate cancer, raising awareness concerning early ... Read More
Research Assistance
